I. Gasquet, L. Nègre-pagès, A. Fourrier, G. Nachbaur, A. El-hasnaoui et al., [Psychotropic drug use and mental psychiatric disorders in France; results of the general population ESEMeD, pp.195-206, 2005.

M. Olfson and S. Marcus, National Patterns in Antidepressant Medication Treatment, Archives of General Psychiatry, vol.66, issue.8, p.848, 2009.
DOI : 10.1001/archgenpsychiatry.2009.81

. Ventes-de-médicaments-aux-officines-et-aux-hôpitaux-en-france, Rapport d'expertise. (Sales of medicines to pharmacies and hospitals in France: key figures 2010. Expertise), 2010.

J. Lepine and I. Gasquet, [Psychotropic drug use in France: changes over time and comparison with other European countries], Bull Acad Natl Med, vol.190, pp.1139-1145, 2006.

A. Ciuna, M. Andretta, L. Corbari, D. Levi, M. Mirandola et al., Are we going to increase the use of antidepressants up to that of benzodiazepines?, European Journal of Clinical Pharmacology, vol.72, issue.9, pp.629-634, 2004.
DOI : 10.1007/s00228-004-0810-8

D. Petty, A. House, P. Knapp, T. Raynor, and A. Zermansky, Prevalence, duration and indications for prescribing of antidepressants in primary care, Age and Ageing, vol.35, issue.5, pp.523-526, 2006.
DOI : 10.1093/ageing/afl023

Y. Chen, C. Kelton, Y. Jing, J. Guo, X. Li et al., Utilization, price, and spending trends for antidepressants in the US Medicaid program, Research in Social and Administrative Pharmacy, vol.4, issue.3, pp.244-257, 2008.
DOI : 10.1016/j.sapharm.2007.06.019

R. Mojtabai and M. Olfson, National Patterns in Antidepressant Treatment by Psychiatrists and General Medical Providers, The Journal of Clinical Psychiatry, vol.69, issue.7, pp.1064-1074, 2008.
DOI : 10.4088/JCP.v69n0704

C. Coupland, P. Dhiman, G. Barton, R. Morriss, A. Arthur et al., A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database, Health Technology Assessment, vol.15, issue.28, pp.1-202, 2011.
DOI : 10.3310/hta15280

A. Grolleau, A. Cougnard, B. Bégaud, and H. Verdoux, [Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey, pp.352-359, 2008.

E. Piek, K. Van-der-meer, W. Hoogendijk, B. Penninx, and W. Nolen, Most Antidepressant Use in Primary Care Is Justified; Results of the Netherlands Study of Depression and Anxiety, PLoS ONE, vol.59, issue.3, p.14784, 2011.
DOI : 10.1371/journal.pone.0014784.t003

B. Arroll, C. Elley, T. Fishman, F. Goodyear-smith, T. Kenealy et al., Antidepressants versus placebo for depression in primary care, Cochrane Database Syst Rev, vol.132, issue.9, 2009.
DOI : 10.1002/14651858.CD007954

J. Stewart, D. Deliyannides, D. Hellerstein, P. Mcgrath, and J. Stewart, Can People With Nonsevere Major Depression Benefit From Antidepressant Medication?, The Journal of Clinical Psychiatry, vol.73, issue.04, pp.518-525, 2012.
DOI : 10.4088/JCP.10m06760

M. Serna, I. Cruz, J. Real, E. Gascó, and L. Galván, Duration and adherence of antidepressant treatment (2003 to 2007) based on prescription database???, European Psychiatry, vol.25, issue.4, pp.206-213, 2010.
DOI : 10.1016/j.eurpsy.2009.07.012

M. Moore, H. Yuen, N. Dunn, M. Mullee, J. Maskell et al., Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database, BMJ, vol.339, issue.oct15 2, p.3999, 2009.
DOI : 10.1136/bmj.b3999

E. Kerr, E. Mcglynn, V. Vorst, K. Wickstrom, and S. , Measuring Antidepressant Prescribing Practice in a Health Care System Using Administrative Data: Implications for Quality Measurement and Improvement, The Joint Commission Journal on Quality Improvement, vol.26, issue.4, pp.203-216, 2000.
DOI : 10.1016/S1070-3241(00)26015-X

R. Mojtabai and M. Olfson, Proportion Of Antidepressants Prescribed Without A Psychiatric Diagnosis Is Growing, Health Affairs, vol.30, issue.8, pp.1434-1442, 2011.
DOI : 10.1377/hlthaff.2010.1024

H. Chen, J. Reeves, J. Fincham, W. Kennedy, J. Dorfman et al., Off-Label Use of Antidepressant, Anticonvulsant, and Antipsychotic Medications Among Georgia Medicaid Enrollees in 2001, The Journal of Clinical Psychiatry, vol.67, issue.06, pp.972-982, 2006.
DOI : 10.4088/JCP.v67n0615

M. Larson, K. Miller, and K. Fleming, Treatment with antidepressant medications in private health plans Adm Policy Ment Health, pp.116-126, 2007.

A. Mercier, I. Auger-aubin, J. Lebeau, P. Van-royen, and L. Peremans, Understanding the prescription of antidepressants: a Qualitative study among French GPs, BMC Family Practice, vol.8, issue.Suppl 2, p.99, 2011.
DOI : 10.1370/afm.1113
URL : https://hal.archives-ouvertes.fr/inserm-00629907

M. Brainin, M. Barnes, J. Baron, N. Gilhus, R. Hughes et al., Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2004*, European Journal of Neurology, vol.60, issue.9, pp.577-581, 2004.
DOI : 10.1016/S0140-6736(98)07507-2

. Haute-autorité-de-santé, Quelle place pour la prégabaline dans les douleurs neuropathiques (What place for pregabalin in neuropathic pain ?) Paris: HAS, 2007.

N. Attal, G. Cruccu, R. Baron, M. Haanpää, P. Hansson et al., EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision, European Journal of Neurology, vol.138, issue.Suppl, pp.1113-88, 2010.
DOI : 10.1111/j.1468-1331.2010.02999.x

P. Dharmshaktu, V. Tayal, and B. Kalra, Efficacy of Antidepressants as Analgesics: A Review, The Journal of Clinical Pharmacology, vol.112, issue.Suppl, pp.6-17, 2012.
DOI : 10.1177/0091270010394852

T. Saarto and P. Wiffen, Antidepressants for neuropathic pain: a Cochrane review, Journal of Neurology, Neurosurgery & Psychiatry, vol.81, issue.12, pp.1372-1373, 2010.
DOI : 10.1136/jnnp.2008.144964
URL : https://hal.archives-ouvertes.fr/hal-00557402

M. Lunn, R. Hughes, and P. Wiffen, Duloxetine for treating painful neuropathy or chronic pain, Cochrane Database Syst Rev, issue.4, 2009.

V. Bril, J. England, G. Franklin, M. Backonja, J. Cohen et al., Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation, Neurology, vol.76, issue.20, pp.1758-1765, 2011.
DOI : 10.1212/WNL.0b013e3182166ebe

M. Alviar, T. Hale, and M. Dungca, Pharmacologic interventions for treating phantom limb pain, Cochrane Database Syst Rev, issue.12, 2011.

S. Evers, J. Afra, A. Frese, P. Goadsby, M. Linde et al., EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force, European Journal of Neurology, vol.46, issue.Suppl 10, pp.968-981, 2009.
DOI : 10.1111/j.1468-1331.2009.02748.x

L. Moja, C. Cusi, R. Sterzi, and C. Canepari, Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches, Cochrane Database Syst Rev, vol.3, issue.2, 2005.
DOI : 10.1002/14651858.CD002919.pub2

D. Urquhart, J. Hoving, W. Assendelft, R. M. Van-tulder, and M. , Antidepressants for non-specific low back pain, Cochrane Database Syst Rev, vol.12, issue.1, 2008.
DOI : 10.1002/14651858.CD001703.pub3

J. Zakrzewska, H. Forssell, and A. Glenny, Interventions for the treatment of burning mouth syndrome, Cochrane Database Syst Rev, vol.77, issue.3, 2005.
DOI : 10.1002/14651858.CD002779.pub2

A. Qaseem, V. Snow, J. Cross, . Jr, M. Forciea et al., Current Pharmacologic Treatment of Dementia: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians, Annals of Internal Medicine, vol.148, issue.5, pp.370-378, 2008.
DOI : 10.7326/0003-4819-148-5-200803040-00008

D. Seitz, N. Adunuri, S. Gill, A. Gruneir, N. Herrmann et al., Antidepressants for agitation and psychosis in dementia, Cochrane Database Syst Rev, issue.2, 2011.

. Haute-autorité-de-santé, HAS): Maladie d' Alzheimer et maladies apparentées: prise en charge des troubles du comportement perturbateurs, (Alzheimer's disease and Alzheimer's related diseases. Management of disruptive behaviour) Paris: HAS, 2009.

S. Ghazi-noori, T. Chung, K. Deane, H. Rickards, and C. Clarke, Therapies for depression in Parkinson's disease, Cochrane Database Syst Rev, vol.69, issue.S1, 2003.
DOI : 10.1002/14651858.CD003465

M. Hackett, M. Yang, C. Anderson, J. Horrocks, and A. House, Pharmaceutical interventions for emotionalism after stroke, Cochrane Database Syst Rev, issue.2, 2010.

S. Intercollegiate and G. Network, Management of patients with stroke: rehabilitation, prevention and management of complications, and discharge planning, A national clinical guideline, 2010.

M. Hackett, C. Anderson, A. House, and C. Halteh, Interventions for preventing depression after stroke, Cochrane Database Syst Rev, issue.3, 2008.

F. Chollet, J. Tardy, J. Albucher, C. Thalamas, E. Berard et al., Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial, The Lancet Neurology, vol.10, issue.2, pp.123-130, 2011.
DOI : 10.1016/S1474-4422(10)70314-8

S. Schutte-rodin, L. Broch, D. Buysse, C. Dorsey, and M. Sateia, Clinical guideline for the evaluation and management of chronic insomnia in adults, J Clin Sleep Med, vol.4, pp.487-504, 2008.

R. Hoque, A. Chesson, and . Jr, Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis, J Clin Sleep Med, vol.6, pp.79-83, 2010.

C. Young, C. Ellis, J. Johnson, S. Sathasivam, and N. Pih, Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis, Cochrane Database Syst Rev, vol.191, issue.1-2, 2011.
DOI : 10.1002/14651858.CD006981.pub2

P. Baldo, C. Doree, P. Molin, D. Mcferran, and S. Cecco, Antidepressants for patients with tinnitus, Cochrane Database Syst Rev, issue.9, 2012.

. Arnhem, The Netherlands: European Association of Urology (EAU), p.4

P. Mariappan, A. Alhasso, A. Grant, N. Dow, and J. , Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults, Cochrane Database Syst Rev, vol.274, issue.4, 2005.
DOI : 10.1002/14651858.CD004742.pub2

C. Roxburgh, J. Cook, and N. Dublin, Anticholinergic drugs versus other medications for overactive bladder syndrome in adults, Cochrane Database Syst Rev, vol.10, issue.1, p.3190, 2007.
DOI : 10.1002/14651858.CD003190.pub4

A. Nationale-d, Accréditation et d'Évaluation en Santé (ANAES): Prise en charge de l'incontinence urinaire de la femme en médecine générale, Recommandations. (Guidelines for management of female urinary incontinence in general practice) Paris: ANAES, 2003.

J. Brown, O. Brien, P. Marjoribanks, J. Wyatt, and K. , Selective serotonin reuptake inhibitors for premenstrual syndrome.I nCochrane Database of Systematic Reviews, 2009.

G. Rada, D. Capurro, T. Pantoja, J. Corbalán, G. Moreno et al., Non-hormonal interventions for hot flushes in women with a history of breast cancer, Cochrane Database Syst Rev, issue.9, 2010.

K. Hatzimouratidis, E. Amar, I. Eardley, F. Giuliano, D. Hatzichristou et al., Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature Ejaculation, European Urology, vol.57, issue.5, pp.804-814, 2010.
DOI : 10.1016/j.eururo.2010.02.020

A. Moreland and E. Makela, Selective Serotonin-Reuptake Inhibitors in the Treatment of Premature Ejaculation, Annals of Pharmacotherapy, vol.3, issue.7-8, pp.1296-1301, 2005.
DOI : 10.1345/aph.1D214

J. Hughes, L. Stead, and T. Lancaster, Antidepressants for smoking cessation, Cochrane Database Syst Rev, issue.1, 2007.

L. Rayner, A. Price, A. Evans, K. Valsraj, I. Higginson et al., Antidepressants for depression in physically ill people, Cochrane Database Syst Rev, issue.3, 2010.

S. Perrot, R. Javier, M. M. , L. Jeunne, C. Laroche et al., Is there any evidence to support the use of anti-depressants in painful rheumatological conditions? Systematic review of pharmacological and clinical studies, Rheumatology, vol.47, issue.8, pp.1117-1123, 2008.
DOI : 10.1093/rheumatology/ken110

L. Ruepert, A. Quartero, N. De-wit, G. Van-der-heijden, G. Rubin et al., Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome, Cochrane Database Syst Rev, vol.68, issue.18, 2011.
DOI : 10.1002/14651858.CD003460.pub3

A. Ford, N. Talley, P. Schoenfeld, E. Quigley, and P. Moayyedi, Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis, Gut, vol.58, issue.3, pp.367-378, 2009.
DOI : 10.1136/gut.2008.163162

P. Mckay, T. Duffy, and C. Martin, Are chronic fatigue syndrome and fibromyalgia the same? Implications for the provision of appropriate mental health intervention, Journal of Psychiatric and Mental Health Nursing, vol.28, issue.10, pp.884-894, 2009.
DOI : 10.1111/j.1365-2850.2009.01464.x

B. Sleath and Y. Shih, Sociological influences on antidepressant prescribing, Social Science & Medicine, vol.56, issue.6, pp.1335-1344, 2003.
DOI : 10.1016/S0277-9536(02)00132-6

J. Mort and R. Aparasu, Prescribing Potentially Inappropriate Psychotropic Medications to the Ambulatory Elderly, Archives of Internal Medicine, vol.160, issue.18, pp.2825-2831, 2000.
DOI : 10.1001/archinte.160.18.2825

X. Briffault, Y. Morvan, F. Rouillon, R. Dardennes, and B. Lamboy, [Factors associated with treatment adequacy of major depressive episodes in France, pp.59-72, 2010.

X. Briffault, Y. Morvan, F. Rouillon, R. Dardennes, and B. Lamboy, [Use of services and treatment adequacy of major depressive episodes in France, pp.48-58, 2010.

B. Smith and N. Torrance, Management of chronic pain in primary care, Current Opinion in Supportive and Palliative Care, vol.5, issue.2, pp.137-142, 2011.
DOI : 10.1097/SPC.0b013e328345a3ec

. Mercier, Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews, BMC Family Practice, vol.5, issue.Suppl 2, p.55, 2013.
DOI : 10.1097/SPC.0b013e328345a3ec
URL : https://hal.archives-ouvertes.fr/inserm-00821288